Does a fecal calprotectin level of 180 imply Inflammatory Bowel Disease (IBD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpreting a Fecal Calprotectin Level of 180 μg/g

A fecal calprotectin level of 180 μg/g falls within the intermediate range (100-250 μg/g) and suggests possible inflammatory bowel disease (IBD) that requires further evaluation, but does not definitively confirm IBD. 1, 2

Diagnostic Significance of Fecal Calprotectin Values

  • Fecal calprotectin is a validated biomarker for intestinal inflammation that correlates well with endoscopic and histological disease activity in IBD 1
  • Values are interpreted according to established thresholds:
    • <100 μg/g: IBS is more likely than IBD 1
    • 100-250 μg/g (including 180 μg/g): Intermediate range requiring clinical correlation 1, 2
    • 250 μg/g: Strongly suggestive of active IBD requiring urgent gastroenterology referral 1

Clinical Approach to a Value of 180 μg/g

  • For patients aged 16-40 with chronic diarrhea and symptoms that may be consistent with either IBD or IBS, a value of 180 μg/g warrants:

    • Exclusion of infectious causes 1
    • Consideration of repeat testing or routine referral to gastroenterology 1
    • Clinical correlation with patient symptoms and risk factors 2
  • The British Society of Gastroenterology recommends that interpretation should consider the pre-test probability of IBD 1:

    • With strong clinical suspicion of IBD (based on clinical features or family history), referral to gastroenterology is advised even for intermediate values like 180 μg/g 1
    • With symptoms more suggestive of IBS, repeat testing may be appropriate 1

Diagnostic Performance at Different Thresholds

  • A meta-analysis found that a calprotectin cut-off of 50 μg/g had the best sensitivity (90.6%) to detect endoscopically active disease 1
  • Specificity performs best (78.2%) at levels >100 μg/g 1
  • A threshold of 250 μg/g provides better specificity (82%) compared to 100 μg/g (66%) for differentiating active IBD from remission 1

Important Caveats and Limitations

  • False positives can occur with:

    • NSAID use in the past 6 weeks 1, 2
    • Infectious gastroenteritis 2, 3
    • Colorectal cancer 1, 2
    • Other inflammatory conditions 2, 3
  • Practical considerations for sample collection:

    • First morning stool is preferred 1
    • Samples should be stored for no more than 3 days at room temperature before analysis 1
    • Variability exists between different assays 1

Next Steps for a Patient with Calprotectin of 180 μg/g

  • Rule out infectious causes with stool cultures 1
  • Consider other baseline tests: CBC, CRP, electrolytes, coeliac screen 1
  • If strong clinical suspicion for IBD exists, refer to gastroenterology 1
  • If symptoms are more consistent with IBS but diagnostic uncertainty remains, consider repeat testing 1
  • For patients with concerning symptoms (rectal bleeding, weight loss, iron deficiency anemia), consider cancer pathway referral regardless of calprotectin value 1

In summary, a fecal calprotectin of 180 μg/g represents an intermediate value that suggests possible IBD but requires clinical correlation and likely further evaluation to establish a definitive diagnosis 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Calprotectin as a Biomarker for Intestinal Inflammation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases.

Clinical and translational gastroenterology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.